Increasing the general knowledge on the regulatory mechanisms of PD-1 under normal physiologic conditions may help us to better understand its regulatory roles in cancer biology and immunotherapy response in melanoma; indeed, one study has already used PD-1 to successfully target immune cells as a cancer immunotherapy [87]. The gene discussed is PDCD1; the disease is melanoma.